The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis.
S P
SP
Georgiadou
R E
RE
Lewis
L
L
Best
H A
HA
Torres
R E
RE
Champlin
D P
DP
Kontoyiannis
D000293:Adolescent; D000328:Adult; D000368:Aged; D019072:Antibiotic Prophylaxis / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015331:Cohort Studies; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D012189:Retrospective Studies; D055502:Secondary Prevention; D014184:Transplantation, Homologous; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*; D055815:Young Adult
D000935:Antifungal Agents; D014230:Triazoles